002349.SZ Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 bal. 2024 @ 10:04):

Jinghua Pharmaceutical Group Co., Ltd. engages in the research and development, manufacture, and sale of APIs and pharmaceutical intermediates in China...

Stats
Dzisiejszy wolumen	10.40M
Średni wolumen	14.60M
Kapitalizacja rynkowa	6.38B
EPS	CNY0.0500 ( 2023-09-30 )
Następna data zysków	( CNY0 ) 2024-05-17
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	26.23
ATR14	CNY0.0100 (0.13%)

Wolumen Korelacja

Długi: 0.15 (neutral)

Krótki: 0.33 (neutral)

Signal:(54.459) Neutral

Jinghua Pharmaceutical Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Jinghua Pharmaceutical Korelacja - Waluta/Towar

0.36
( neutral )

0.44
( neutral )

0.00
( neutral )

-0.73
( moderate negative )

-0.38
( neutral )

Jinghua Pharmaceutical Finanse

Annual	2023
Przychody:	CNY1.49B
Zysk brutto:	CNY692.96M (46.49 %)
EPS:	CNY0.300

FY	2023
Przychody:	CNY1.49B
Zysk brutto:	CNY692.96M (46.49 %)
EPS:	CNY0.300

FY	2022
Przychody:	CNY1.57B
Zysk brutto:	CNY735.15M (46.73 %)
EPS:	CNY0.260

FY	2021
Przychody:	CNY1.36B
Zysk brutto:	CNY632.18M (46.56 %)
EPS:	CNY0.200

Financial Reports:

No articles found.

Jinghua Pharmaceutical

Jinghua Pharmaceutical Group Co., Ltd. engages in the research and development, manufacture, and sale of APIs and pharmaceutical intermediates in China. Its primary products include Phenylbutazone, Primidone, Phenobarbital, Fluorouracil, Propylthiouracil, Piroxicam, and Flucytosine APIs. The company was formerly known as Nantong Jinghua Pharmaceutical Co., Ltd. Jinghua Pharmaceutical Group Co., Ltd. was founded in 1957 and is based in Nantong, China.